À Propos de l'Entreprise
- Raison sociale: Hangzhou Longshine Bio-Tech Co., Ltd.
- Nom international: Hangzhou Longshine Bio-Tech Co., Ltd., Hangzhou, Zhejiang, China
- Marque / Nom commercial: Longshine Bio-Tech
- Pays d'enregistrement: China
- Adresse: China Mainland Zhejiang Hangzhou 5-405, Matrix International Center, No. 515, Yuhangtang Road, Gongshu District, Hangzhou • Zhejiang
Description:
Founded in 2011 and headquartered in Gongshu District, Hangzhou, Hangzhou Longshine Bio-Tech Co., Ltd. manufactures and trades active pharmaceutical ingredients, intermediates, bio products, and natural extracts, including chiral intermediates and prophylactic biological products. The company became an approved supplier to Bayer in 2013, earned ISO 9001 certification in 2017, and in 2018 invested in the Dalian Wondersun API and vitamins factory. Its customers include Bayer, Cipla, Sun Pharma, and Hikma, and it offers CDMO services along with OEM production, shipping on FOB, CIF, CIP, CPT, or DDP terms with L/C, T/T, or D/P payment, competing on brand strength, R&D experience, delivery speed, production capacity, and a broad product line.
Activités Commerciales
Principes Actifs Pharmaceutiques (API)
FournisseurExportateurDistributeurPrestataire de ServicesAgence / ReprésentantFabricant
Extraits Naturels & Ingrédients Botaniques
FabricantDistributeurPrestataire de ServicesAgence / Représentant
Produits Chimiques Pharmaceutiques
FabricantDistributeurPrestataire de ServicesAgence / Représentant
Services de Laboratoire & d'Analyse
FabricantDistributeurPrestataire de ServicesAgence / Représentant
Marchés de Vente
- Eastern Europe: Bulgaria, Czech Republic, Hungary
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Active Pharmaceutical Ingredients
- Produits Chimiques Pharmaceutiques: 4,5-Dimethoxy-1-cyanobenzocyclobutane, API & INTERMEDIATES, 2.2.2-Trifluoroethyl Trifluoromethanesulfonate, Cyclopenta[2,1-b;3,4-b']dithiophen-4-one, CAL-101, 1,1,1-Trifluoro-2-(trifluoromethyl)pent-4-en-2-ol, 7, 8-Dimethoxy-1,3,4,5-tetrahydro-benzo[D]Azepin-2-one, Methoxyphenyl acetone, (R)-3,6-diethoxy-2,5-dihydro-2-isopropylpyrazine, Growth hormone products
- Produits Biopharmaceutiques: Marbofloxacin, 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride, Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid, (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile, Boc-3-Hydroxy-1-adamantyl-D-glycine, (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester, 2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile, (S)-3-1-Dimethylamino Ethyl Phenol, 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tat, Fondaparinux sodium, 5-Bromo-2,4-dichloropyrimidine, β-Amino-α-hydroxycyclobutanebutanamide Hydrochloride, 1-[[2-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-, methyl ester, 1-(2-cyanobiphenyl-4-yl-methyl)- 2-ethoxybenzimidazole-7-carboxylic acid ethyl ester, 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile, 1-(3-methyl-1-phenyl-1H-pyrazole-5-yl) piprazine, 1-BENZYL-4-methyl PIPERIDINE-3-ONE, 17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate, (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium, (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane hydrochloride, (1S,3aR,6aS)-butyl octahydrocyclopenta[c]pyrrole-1-carboxylate oxalate, (1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one, 2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one, 2-(4-fluorophenyl)-5-(5-bromo-2-methylbenzyl)thiophene, 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate, 2,3-Dichloro-6-nitrobenzaldehyde, 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide, 2,6-Dilfuorobenzyl Bromide, (2R,4R) 4-METHYL 2-PIPERIDINE CARBOXYLIC ACID, (2R,4R) ETHYL- 4-METHYL 2-PIPERIDINE CARBOXYLATE, (2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate, [{(2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxycarbonyl)amino-1,6-diphenyl hexane} Succinic acid sa, 3'-amino-2'-hydroxy-biphenyl-carboxylic acid, 3-Fluoro-4-methylphenylisothiocyanate, (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahy, 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-5-yl)ethylbenzoic acid, 4-Bromo-2-fluoro-N-methylbenzamide, 4-Oxo-1,4-Dihydroquinoloine -3-Carboxylic Acid, 5-(1-Piperazinyl)benzofuran-2-carboxamide, 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H- indole-7-carbonitrile(2R,3R)-2,3-dih, 5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole, 5-((Z)-(5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone, Arsenazo III, Benzyl2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl) propan-2-yl, Carnidazole, Conjugated Estrogens (GMP, COS), Cyclopenta[c]pyrrole-1-carboxylic acid, octahydro-, ethyl ester, hydrochloride, (1S,3aR,6aS)-, Dapoxetine HCL, Diethyl 2-(acetamido)-2-(2-(4-octylphenyl)ethyl)propanedioate, Diethyl (3-Pyridyl) Borane, (E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, Ethyl-2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate, Ethyl-5amino-1-benzofuran-2carboxylate, Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate, ETHYL[(2,3-DICHLORO-6-NITRO-BENZYL)AMINO]ACETATE, LORCASERIN, N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine, N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, N-methyl-2-sulfanylbenzamide, N-Methyl-N-((3R,4R)-4-methylpiperidin-3yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, Praziquantel (FDA), (S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic acid, (S)-2-Naphthalenamine, 1,2,3,4-tetrahydro-5-hydroxy-N-propyl-, hydrobromide, Tert-Butyl(1R,2S,5S)-2-zido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate, (Z)-ethyl 2-chloro-2-(2-(4-Methoxyphenyl)hydrazono)acetate
Nos Produits & Services
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Pharma Chemicals
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Certifications
ISO9001
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire